Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
More importantly, the extension for filing a quarterly report is only 5 calendar days from the day the extension is requested. To request an automatic extension, a company must file a Form 12b-25 no later than the day after the report was due.
That being said, the last day they can request an automatic extension is May 16th, and 5 calendar days from that is May 21st.
That means that worst case scenario is waiting out the weekend, notwithstanding extraordinary circumstances.
The 10-K seemed to come out so late because they were given 15 calendar days from the day they submitted the Form 12b-25, then they waited every single one of those days before releasing he report. As we all know, a lot can happen in 15 days on the OTC market.
Luckily, we shouldn’t have that problem this time, and even if they’re late it’s only a few days.
Hope that eases any concerns folks might have.
I think Q1 numbers will be the most anticipated piece of news for Canbiola this year.
Thus far, all performance speculation has come in short, and Q1 is expected to be huge. I think we will continue to be surprised by the way Canbiola exceeds everyone’s expectations.
I’ve been holding for several months, but I made the tough decision to sell my position in Canbiola last week. Fortunately, I’ve been very successful this week with other plays, and I’ll be able to increase my CANB position by at least 50% ahead of Q1.
With the amount of potential in the foreseeable future, Canbiola is an obvious winner. The only thing that can make it better is getting my hands on more shares!
Good luck to all!
I thought yesterday was the end of PIR, but I’m glad to see such a strong recovery.
Admittedly, I got scared after the huge sell off and I got shaken out of about 1,000 shares.
I’m back in now and it’s looking up from here!
Congrats to all the longs!
Old news. This was initially announced in the beginning of April.
The share price has risen almost 100% since then, and by the looks of the chart is set to rise more this week.
The share increase is already factored into the current share price.
Although there are no plans to issue these additional shares, there has been speculation of a merger in 2019. Maybe that’s what what they’ll be used for, but other posters may be able to comment on that in more detail.
At this point, I wouldn’t be discouraged by the increase too much.
At this time, the shares are only authorized, not issued.
They are not included in the public float, they are not held by anyone, and they are not tradable. They have not been used in anyway whatsoever.
No problem, always glad to help!
The stock isn’t being diluted with 1.5 billion shares.
The increase will only authorize more shares, but they will not be issued.
Dilution occurs when the outstanding share count is increased - that is not what is happening here.
I wouldn’t really call it news, since we already knew about Canbiola’s intent to increase the authorized share count.
On April 1st, Canbiola released a PRE 14C, explaining that they would be increasing the authorized share count to 1.5 billion.
Here’s the link:
http://app.quotemedia.com/quotetools/showFiling.go?webmasterId=501&name=CANBIOLA,%20INC.:%20PRE%2014C,%20Sub-Doc%201&link=http%3A//quotemedia.10kwizard.com/filing.xml%3Frid%3D23%26ipage%3D12814050%26DSEQ%3D1%26SQDESC%3DSECTION_BODY%26doc%3D1&cp=on&type=HTML
It was discussed ad nauseam on this board, so for more points on the issue you can scroll down to the beginning of April.
Some bigger points to consider, however, are:
1) its an increase to the authorized share count, not the outstanding share count. The shares are not issued and do not affect Canbiola’s float.
2) The company does not have plans to issue these shares, but if they do, they will likely be used to fund operations if needed.
3) most importantly, thanks to the PRE 14C released April 1st, this became public knowledge a month ago. Since then, the share price has doubled and held on to most of it. I would think it’s safe to say that the impact of this increase is already built in to the share price.
Canbiola looks as strong as ever. Not many companies can run more than 85% in a few days without giving most of it back.
To think that Canbiola ran 85% from its lows two weeks ago and has only given back 15% speaks volumes of this company’s strength.
Moreover, it tells the story of investor sentiment, and that the market still doesn’t think that Canbiola is overvalued - even after making such huge gains.
To me, everything is pointing toward another big run, and I suspect we will see another 100% from these levels very soon.
The timing couldn’t be any better, just two weeks away from reporting record breaking revenue. If anyone was waiting for ‘the’ catalyst of 2019, this is it.
As we add another 100% over the next two weeks and report record breaking revenue, we will see the perfect storm developing. At the very least, we should expect new highs. If Canbiola really generates traction, we could see the next 2,000% gainer in the CBD sector be born.
With that said, I’m glad I was able to add another 35,000 shares on Friday. Good luck to everyone!
Question:
Has anyone been able to find out more information regarding the J&J, Aetna, Canbiola symposium?
All I’ve gathered is that it has to do with active duty/veteran treatment options and it’s in San Antonio.
I’m a veteran and San Antonio local, so I wouldn’t mind attending if possible. I just don’t know when/where it’s being held.
I’m kicking myself also!
I expected the bounce off of $.45, and when I saw the volume picking up, I bought back in at $.47. When it slowed down at $.55, I sold at $.53.
I know that this ticker has nothing but upside potential over the long run, but I expected a bigger sell off with it being Friday and all.
Nope, just picked back up and went running again!
Lesson learned: never doubt the strength of EDXC!
I’m glad to see us tap $.051 and turn around, just like I expected.
If I’m being honest though, I REALLY wanted more $.04’s - but I’m greedy!
I’m expecting $.06’s all next week, news could bring $.07’s.
Have a great weekend everyone!
I’m glad to see $.45 holding at this point.
For the time being, I think $.45 is a good support level. We’ll see what next week brings.
If you look at the hourly chart, not the daily chart, it’s more apparent.
Last Thursday we closed at $.048. On Monday, however, we gapped up to opened at $.0527.
Aside from our typical consolidation, I suspect we are working to fill that void.
I image we will hit the $049 - $.05 range, bounce off of the 50-day SMA line, and climb right back out.
The hourly chart is still showing a gap in $.05 - $.052 range. Based on today’s close, I suspect tomorrow will open with a gap down to fill the void, then climb out rather quickly.
One thing I noticed about today’s close was that there were plenty of buyers stepping in and taking advantage of the low $.05’s. That leads me to believe that a gap down will entice even more buyers tomorrow. If anything, I’ll be buying anything and everything under $.05 if it goes that low!
A few things to keep in mind as we move into next week:
1) This week’s selling is likely attributed to profit takers who bought in around $.03 earlier this month. At current prices, they’re still making a hefty profit - even in the low $.05’s. As these shares switch hands, we’ll see a much stronger base form at this level.
2) Consolidation around this level is critical, primarily for the purpose of building enough momentum for the next move up.
For example, after running up almost 100% from the low-$.03’s, we ran out of steam this week and weren’t able to maintain a breakout above $.06. As we consolidate around $.05, maintaining a breakout about $.06 will be much easier.
3) Finally, and perhaps the most important thing to take away from this week’s trading, is that we are mirroring almost exactly last November’s run to $.10.
Last November, we ran from the low $.03’s to the mid-$.06’s, consolidated around the low-$.05’s, and then shot up to $.10 in just three sessions.
At the very least, I expect this pattern to repeat itself. When you consider the recent shift in investor sentiment, however, I expect to surpass $.10 and reach new highs.
With all that being said, Canbiola looks to be trading healthily and happily! The next week or two will be very exciting to watch!
Well, the dip worked out as expected, but we didn’t quite get the bounce I was hoping for.
Nonetheless, $.50 - $.51 held up pretty well today, and we saw a lot of shares traded in that range. I think we’ve got a solid base for our leg up.
All in all, I’m glad to see $EDXC holding up well, and I’m looking forward to the next run.
Good luck to everyone!
After yesterday’s mania, watching today’s trading is like watching paint dry.
Looks like $.51 is holding.
This would be a good entry point for today, before we climb back to $.60.
Wait for the bounce off of mid-$.40’s support before buying back in!
Don’t get caught trying to catch a falling knife!
I’d like to see $.45 hold, otherwise it’s going to $.40.
If we have another wave of selling this morning, and stop losses get taken out again, we could see a dip down to the mid-$.40’s. If that happens, I’ll be looking to buy between $.44 and $.47.
If it does dip, I’m confident it will climb back out in yesterday’s fashion.
If we don’t dip, I expect us to battle with resistance around $.67 today. A solid break through could take us back to the $.70 to $.75 range.
Hey, thanks everybody! I’m pretty new to iHub, and gathering a following was never my goal. I just enjoy what we’re doing here: making money!
I recently finished my second year of law school and decided it wasn’t for me. I found myself trading during class most days, instead of listening to lectures. So I decided to leave school and I’ve been trading full-time ever since.
I just hope to add some substantive value to the board while I’m here!
Thanks for all the kind words!
That stuck out to me as well. In fact, when I read the 10K, and noticed it didn’t include any extra fluff, it reminded me of CV Sciences.
I’ve followed CVSI for quite a while and that’s one thing that their execs don’t do. They don’t exaggerate, they don’t speculate, and they don’t share more than there is to tell.
On one hand, short-term holders are disappointed that the company doesn’t do more to inflate the share price. On the other, long-term holders appreciate the professionalism of the company.
It’s great to see Canbiola taking a play out of CV Sciences playbook, and I’m sure they share a similar long-term vision for their company.
After today, all gaps down are welcome!
And the lesson is:
BUY EVERY SINGLE DIP!
Absolutely! It can’t be said enough: EDXC is unstoppable!
After today’s rollercoaster, anyone care to predict how tomorrow might be? How the rest of the week might be?
WHAT A COMPANY!
EDXC is going to put a lot of people into early retirement!
Here comes $1.00!
I’m sure many folks were flushed out by their stop losses.
I’ve been hoping to buy back in around $.50, but was lucky enough to grab some $.38’s thanks to the panic.
This is easily headed over $1.00 within the next couple weeks. If we get some substantive news, the top might just blow off of this thing!
Congrats to everyone who weathered the storm, and all those who took advantage of the discount prices this morning!
Agreed! I was suspected a panic after yesterday, and I thought it might drop to the $.30’s, but I NEVER expected it to recover 100% a few hours later!
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=148367709
Yup, can’t believe we’re down 2% after being up 70% in 6 trading sessions. What a terrible company.
This is exactly what I was worried about, and why I didn’t buy back in at $.50.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=148367709
Very true, their product lines are drastically different.
The end result, however, is revenue. Whatever CBD product they’re selling doesn’t necessarily matter. Instead, the question is: how much money are they making?
CBD Unlimited and Canbiola, although they approach the CBD market very differently, generated about the same revenue in 2018. If I remember correctly, CBD Unlimited brought in about $800,000 and Canbiola brought in just under $700,000.
Going forward, CBD Unlimited is expecting to drive $2 million in retail sales each month in 2019, bringing in $24 million for the year.
Likewise, Canbiola is expecting to have 1,650 SAM units distributed in 2019, bringing in $23 million - not including their retail arm.
So, yes, their product line and their approach to the CBD market is very different, but the companies are driving very similar revenue. In that regard, the comparison is extremely valuable in determining market capitalization.
Even if we are red tomorrow, we gained 30% today.
We won’t give it all back, and we’re still looking strong going forward.
It’s too little, too late to spook people out of Canbiola at this point. The potential is becoming more and more clear as we go - and people like what they see.
I think we all are!
Even if they are late, the bright side is that the won’t be allowed another 15-day extension. They’ll only get 5 days.
So the very latest they’ll be allowed to file (with an extension) will be May 23. Just expect them on that day.
Agreed. I would have liked to see a more controlled consolidation period over the next few trading sessions.
At this point, I’m concerned that the dramatic price movement will induce panic selling.
The quicker this drops, many of the buyers from this last leg will likely try to salvage smaller profits or mitigate losses before it’s too late.
If that happens, we could easily be headed back to the $.30 - $.40 range.
No shame in that! We all get a little optimistic sometimes when it comes to tickers we like!
I think the next 2-3 trading will provide great buying opportunities.
The only thing that concerns me about this sell off is that the hourly chart has broken down in a way that hasn’t happen with the last runs. The price is now below the 50-day SMA line, and well below the 14-day SMA line - something I’ll be watching closely before buying back in.
Nonetheless, if the daily chart holds up, we might see another bounce of the 14-day SMA line and be back in business by the end of the week.
$.065 looks like our next level of resistance, so a close above that would be great.
At this point, it’s hard to tell how quickly this is going to run. I didn’t expect to run through $.05’s as quickly as we did, so there’s no telling how quickly we’ll run through $.06’s.
When I said that $.05 wouldn’t be available for much longer, I had no idea they’d be gone less than an hour later!
This ticker is trading just like $EDXC has been - it moves!
The intraday low is in, yes. The consolidation, however, is far from over.
Every run, since $.04, has been preceded by a bounce of the 14-SMA line. The next few days will bring us closer to the moving averages, where this will find much more support, and then it will start to climb again.
If you’re looking for an entry point on this week’s consolidation, keep in mind that the last leg ran to $.40 and gave back 25% over the following 2 weeks.
The leg prior to that ran up to $.18 before giving back about 30% and finding support around $.125.
The prevailing trend over the last 4 months, has been 20-30% pull backs after each run.
After hitting $.75, a 25% pull back puts us in the high $.50’s.
Exactly what this ticker should be doing right now. All of the indicators are way over extended and it needs time to cool.
Like I mentioned last week, this week should bring continued consolidation, dropping it down to the mid-$.50’s.
Keep in mind that this ticker has shown us how quickly it can reverse a trend. The consolidation could only be a few days before it starts its next leg up.
Nonetheless, this week will provide a great opportunity to buy.